Florida Financial Advisors LLC acquired a new position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The fund acquired 9,105 shares of the company's stock, valued at approximately $211,000.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. UMB Bank n.a. boosted its holdings in shares of Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after buying an additional 346 shares during the period. Signaturefd LLC raised its position in shares of Option Care Health by 487.9% during the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after purchasing an additional 1,005 shares during the period. Quarry LP lifted its holdings in shares of Option Care Health by 327.7% in the 3rd quarter. Quarry LP now owns 3,430 shares of the company's stock worth $107,000 after purchasing an additional 2,628 shares during the last quarter. Blue Trust Inc. boosted its position in Option Care Health by 16.9% during the 4th quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock valued at $109,000 after purchasing an additional 681 shares during the period. Finally, Venturi Wealth Management LLC boosted its holdings in shares of Option Care Health by 2,621.3% during the fourth quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company's stock valued at $110,000 after acquiring an additional 4,561 shares during the period. 98.05% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several brokerages have recently issued reports on OPCH. Bank of America upgraded Option Care Health from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and lifted their target price for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. JPMorgan Chase & Co. upped their price target on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. UBS Group initiated coverage on shares of Option Care Health in a research note on Thursday, December 5th. They issued a "neutral" rating and a $26.00 price objective on the stock. Finally, Barrington Research increased their target price on shares of Option Care Health from $33.00 to $38.00 and gave the company an "outperform" rating in a research note on Thursday, February 27th. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $33.00.
Get Our Latest Report on Option Care Health
Option Care Health Stock Down 1.3 %
OPCH traded down $0.47 on Friday, reaching $34.73. 1,378,809 shares of the company traded hands, compared to its average volume of 1,713,822. The company has a market cap of $5.70 billion, a price-to-earnings ratio of 29.18, a PEG ratio of 2.30 and a beta of 1.33. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The stock's 50 day moving average price is $32.47 and its 200-day moving average price is $28.41. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53.
Insiders Place Their Bets
In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.64% of the company's stock.
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Articles
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
